Hanwha Group’s Qcells plan is the latest example of a rush of money spurred by tax incentives

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Weight-loss drugs like Wegovy are meant for long-term use. What happens if you stop?

Millions of Americans who have dropped pounds and boosted their health using…

Authorities to Return Items Seized in Kansas Newspaper Raid

The Marion County Record, a newspaper in Kansas that the police raided…

Using stem cells, doctors restored vision to people with devastating eye injuries

It was the Fourth of July in 2020 when Nick Kharufeh’s life…

Suez Canal Has Reopened, but Ever Given Isn’t Free to Go

CAIRO—Egypt won’t release the massive container ship that blocked the Suez Canal…